Beginner's Mind
Blueprints for Builders and Investors
Hosted by Christian Soschner
From pre-seed to post-IPO, every company—especially in deep tech, biotech, AI, and climate tech—lives or dies by the frameworks it follows.
On Beginner’s Mind, Christian Soschner uncovers the leadership principles behind the world’s most impactful companies—through deep-dive interviews, strategic book reviews, and patterns drawn from history’s greatest business, military, and political minds.
With over 200 interviews, panels, and livestreams, the show ranks in the Top 10% globally—and is recognized as the #1 deep tech podcast.
With 35+ years across M&A, company building, board roles, business schools, ultrarunning, and martial arts, Christian brings a rare lens:
What it really takes to turn breakthrough science into business—how to grow it, lead it, and shape the world around it.
🎙 Expect each episode to deliver:
- Founder & Investor Blueprints: How breakthrough technologies scale from lab to IPO
- Historical & Biographical Frameworks: Timeless playbooks from the world's great builders
- Leadership & Communication Mastery: Tools to inspire, persuade, and lead at scale
Whether you're building the next biotech success, investing in AI, or leading a climate tech company through hypergrowth—this podcast gives you the edge.
Listen in. Apply what matters. Build companies that last.
📬 Join the newsletter & community: https://lsg2g.substack.com/
Beginner's Mind
MM 17: Daniel Vitt: Munich's Biotech Surge: The Untold Story Behind Europe's Innovation Hub
Munich, Bavaria - a picturesque city known for its rich history and Oktoberfest. But did you know it's also the epicenter of Europe's biotech revolution? Dive into this captivating conversation with Dr. Daniel Vitt, the driving force behind Immunic Therapeutics, as he unravels the secrets of Munich's meteoric rise in the biotech realm.
1️⃣ Munich's Meteoric Rise:
Discover how Munich transformed into one of Europe's most dynamic biotech ecosystems, and the role of visionary political decisions in its ascent.
2️⃣ Inside Immunic's Journey:
From its inception to its transformative stages, journey with Dr. Vitt as he shares the challenges and triumphs of leading a biotech giant. Learn about Immunic's groundbreaking developments and its innovative approach to treating diseases like multiple sclerosis.
3️⃣ About Dr. Daniel Vitt:
Dr. Daniel Vitt, CEO of Immunic Therapeutics, is a biotech luminary with a rich legacy, including co-founding 4SC AG. His insights offer a rare glimpse into the intricacies of the global biotech landscape, from Europe to the US.
Full Episode
📢 Engage with Us:
If this narrative resonates with you, please subscribe, like, comment, and share. Your support amplifies our voice, bringing more such enlightening tales to the forefront.
🎉 Dive In:
Embark on this enlightening journey into the world of biotech innovation. Let's explore the stories of those shaping our tomorrow.
Join the Podcast Newsletter: Link
